Vietnam · Delayed Price · Currency is VND Ligand Pharmaceuticals Statistics
Total Valuation
HNX:VC3 has a market cap or net worth of VND 3.81 trillion. The enterprise value is 3.72 trillion.
| Market Cap | 3.81T |
| Enterprise Value | 3.72T |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HNX:VC3 has 136.41 million shares outstanding. The number of shares has increased by 11.42% in one year.
| Current Share Class | 136.41M |
| Shares Outstanding | 136.41M |
| Shares Change (YoY) | +11.42% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | n/a |
| Float | 136.32M |
Valuation Ratios
The trailing PE ratio is 37.66.
| PE Ratio | 37.66 |
| Forward PE | n/a |
| PS Ratio | 5.83 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.51, with an EV/FCF ratio of -166.58.
| EV / Earnings | 36.79 |
| EV / Sales | 5.69 |
| EV / EBITDA | 26.51 |
| EV / EBIT | 27.39 |
| EV / FCF | -166.58 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.85 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.80 |
| Debt / FCF | -5.02 |
| Interest Coverage | 221.93 |
Financial Efficiency
Return on equity (ROE) is 7.04% and return on invested capital (ROIC) is 5.46%.
| Return on Equity (ROE) | 7.04% |
| Return on Assets (ROA) | 2.74% |
| Return on Invested Capital (ROIC) | 5.46% |
| Return on Capital Employed (ROCE) | 9.05% |
| Revenue Per Employee | 8.59B |
| Profits Per Employee | 1.33B |
| Employee Count | 76 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.24 |
Taxes
In the past 12 months, HNX:VC3 has paid 33.17 billion in taxes.
| Income Tax | 33.17B |
| Effective Tax Rate | 24.69% |
Stock Price Statistics
The stock price has increased by +9.78% in the last 52 weeks. The beta is -0.15, so HNX:VC3's price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | +9.78% |
| 50-Day Moving Average | 26,030.95 |
| 200-Day Moving Average | 25,629.30 |
| Relative Strength Index (RSI) | 70.95 |
| Average Volume (20 Days) | 855,540 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:VC3 had revenue of VND 653.05 billion and earned 101.07 billion in profits. Earnings per share was 740.76.
| Revenue | 653.05B |
| Gross Profit | 197.42B |
| Operating Income | 135.66B |
| Pretax Income | 134.31B |
| Net Income | 101.07B |
| EBITDA | 140.17B |
| EBIT | 135.66B |
| Earnings Per Share (EPS) | 740.76 |
Balance Sheet
The company has 219.86 billion in cash and 111.96 billion in debt, giving a net cash position of 107.90 billion or 790.95 per share.
| Cash & Cash Equivalents | 219.86B |
| Total Debt | 111.96B |
| Net Cash | 107.90B |
| Net Cash Per Share | 790.95 |
| Equity (Book Value) | 1.49T |
| Book Value Per Share | 10,753.62 |
| Working Capital | 1.30T |
Cash Flow
In the last 12 months, operating cash flow was -22.32 billion and capital expenditures -622,000, giving a free cash flow of -22.32 billion.
| Operating Cash Flow | -22.32B |
| Capital Expenditures | -622,000 |
| Free Cash Flow | -22.32B |
| FCF Per Share | -163.63 |
Margins
Gross margin is 30.23%, with operating and profit margins of 20.77% and 15.48%.
| Gross Margin | 30.23% |
| Operating Margin | 20.77% |
| Pretax Margin | 20.57% |
| Profit Margin | 15.48% |
| EBITDA Margin | 21.46% |
| EBIT Margin | 20.77% |
| FCF Margin | n/a |
Dividends & Yields
HNX:VC3 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.42% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.66% |
| FCF Yield | -0.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2025. It was a forward split with a ratio of 1.09.
| Last Split Date | Aug 1, 2025 |
| Split Type | Forward |
| Split Ratio | 1.09 |
Scores
HNX:VC3 has an Altman Z-Score of 2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | 3 |